Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Due to these properties, they represent promising candidates for the development of more stable and efficacious research compounds, particularly when targeting proteinprotein interactions
CoA-LOT: BN280107/CA
Our healthcare providers conduct thorough assessments to determine the most suitable treatment course, ensuring that patients receive the right care at the right cost
Clinical Therapeutics
HaCaT keratinocytes have also been proven to be good candidates for assessing skin irritancy and toxicity in conventional monolayer assays measuring using MTT reduction as the viability endpoint 21
US$ 29.31
US$ 27.02
US$ 29.41
US$ 22.45
US$ 21.87
